BioCentury
ARTICLE | Company News

Molecular Geriatrics, The Upjohn Co. deal

October 16, 1995 7:00 AM UTC

Upjohn (Kalamazoo, Mich.) acquired Molecular Geriatrics' assay to detect Alzheimer's Disease Associated Protein (ADAP). An excess of the abnormal proteins in the brain has been associated with Alzheim...